Announcements and other releases
- Statement regarding possible offer by Advanced Medical Solutions Group plc
- Response statement regarding possible offer by H.B. Fuller Company
- Statement by H.B. Fuller Company
- Statement regarding deadline extension by Advanced Medical Solutions Group plc
- Rule 2.7 announcement - H.B. Fuller Medical Adhesive Technologies Inc. offer for Advanced Medical Solutions Group plc - 25 June 2026
- Investor presentation - H.B. Fuller Announces Offer to Acquire Advanced Medical Solutions Group plc - 25 June 2026
- Press statement - H.B. Fuller Announces Offer to Acquire Advanced Medical Solutions Group plc - 25 June 2026
- Scheme document publication announcement - 20 July 2026
Scheme document
- Scheme document - 20 July 2026
- Specimen form of proxy - court meeting
- Specimen form of proxy - general meeting
- Bylaws of H.B. Fuller Medical Adhesive Technologies Inc.
- Articles of association of Advanced Medical Solutions Group plc
- Draft of amended articles of association of Advanced Medical Solutions Group plc
Share plan communications
- Rule 15 letter – DBP – 20 July 2026
- Rule 15 letter – LTIP – 20 July 2026
- Rule 15 letter – ESOS – 20 July 2026
- Rule 15 letter – GSOP – 20 July 2026
- Rule 15 letter – CSOP – 20 July 2026
- Rule 15 letter – ESPP – 20 July 2026
- Non-Rule 15 letter – SIP – 20 July 2026
- Non-Rule 15 underwater letter – GSOP, CSOP, ESOS – 20 July 2026
Offer related arrangements
- Confidentiality agreement between Advanced Medical Solutions Group plc and H.B. Fuller Company - 10 May 2026
- Co-operation agreement between H.B. Fuller Medical Adhesive Technologies Inc. and Advanced Medical Solutions Group plc - 25 June 2026
- Regulatory clean team agreement between H.B. Fuller Medical Adhesive Technologies Inc. and Advanced Medical Solutions Group plc - 25 June 2026
Irrevocable undertakings
- Irrevocable undertaking from Chris Meredith - 25 June 2026
- Irrevocable undertaking from Edward Johnson - 25 June 2026
- Irrevocable undertaking from Grahame Cook - 25 June 2026
- Irrevocable undertaking from Susan Searle - 25 June 2026
Consent letters
- Rule 2.7 announcement consent letter given by Perella Weinberg Partners – 24 June 2026
- Rule 2.7 announcement consent letter given by Goldman Sachs – 25 June 2026
- Rule 2.7 announcement consent letter given by Evercore – 25 June 2026
- Rule 2.7 announcement consent letter given by Investec Bank plc – 25 June 2026
- Scheme document consent letter given by Perella Weinberg Partners – 20 July 2026
- Scheme document consent letter given by Goldman Sachs – 20 July 2026
- Scheme document and Rule 15 consent letter given by Evercore – 20 July 2026
- Scheme document and Rule 15 consent letter given by Investec Bank plc – 20 July 2026
Financing
- Engagement letter (Bank Financing) (Goldman Sachs Bank USA and H.B. Fuller Company) - 25 June 2026
- Fee and syndication letter (Goldman Sachs Bank USA and H.B. Fuller Company) - 25 June 2026
- Agency fee letter (Goldman Sachs Bank USA and H.B. Fuller Company) - 25 June 2026
- Credit agreement (Secured Bridge) - 25 June 2026
- Credit agreement (Unsecured Bridge) - 25 June 2026
- A&R Engagement Letter (Bank Financing) – 17 July 2026
- A&R Engagement Letter (Securities Offering) – 17 July 2026
- A&R Fee and Syndication Letter – 17 July 2026
- A&R Fee Credit Letter (Unsecured Bridge) – 17 July 2026
- A&R Agency Fee Letter– 17 July 2026